Abstract:The gut microbiota is involved in the pathogenesis of diarrhea-predominant irritable bowel syndrome (IBS-D), but few studies have focused on the role of the gut virome in IBS-D. We aimed to explore the characteristics of the gut virome in patients with IBS-D, its interactions with bacteria and metabolites, and the associations between gut multiomics profiles and symptoms. This study enrolled twelve patients with IBS-D and eight healthy controls (HCs). The stool samples were subjected to metavirome sequencing, 16S rRNA gene sequencing, and untargeted metabolomic analysis. The participants completed relevant scales to assess the severity of their gastrointestinal symptoms, depression, and anxiety. The results revealed unique DNA and RNA virome profiles in patients with IBS-D with significant alterations in the abundance of contigs from Siphoviridae, Podoviridae, Microviridae, Picobirnaviridae, and Tombusviridae. Single-omics co-occurrence network analyses demonstrated distinct differences in the gut virus, bacteria, and metabolite network patterns between patients with IBS-D and HCs. Multiomics networks revealed that short-chain fatty acid-producing bacteria occupied more core positions in IBS-D networks, but had fewer links to viruses. Amino acids and their derivatives exhibit unique connectivity patterns and centrality features within the IBS-D network. The gastrointestinal and psychological symptom factors of patients with IBS-D were highly clustered in the symptom-multiomics network compared with those of HCs. Machine learning models based on multiomics data can distinguish IBS-D patients from HCs and predict the scores of gastrointestinal and psychological symptoms. This study provides insights into the interactions among gut viruses, bacteria, metabolites, and clinical symptoms in patients with IBS-D, indicating further classification and personalized treatment for IBS-D.

Gut virome-wide association analysis identifies cross-population viral signatures for inflammatory bowel disease

Interpersonal variability of the human gut virome confounds disease signal detection in IBD

Metagenomic analysis of microbiome in colon tissue from subjects with inflammatory bowel diseases reveals interplay of viruses and bacteria

Integrated 16S rRNA sequencing and metagenomics insights into microbial dysbiosis and distinct virulence factors in inflammatory bowel disease

Gut virome in inflammatory bowel disease and beyond

Multiomic spatial analysis reveals a distinct mucosa-associated virome

Cataloguing and profiling of the gut virome in Chinese populations uncover extensive viral signatures across common diseases

Metagenomic analysis of the gut virome in patients with irritable bowel syndrome

Metagenomic analysis of intestinal mucosa revealed a specific eukaryotic gut virome signature in early-diagnosed inflammatory bowel disease

The gut ileal mucosal virome is disturbed in patients with Crohn’s disease and exacerbates intestinal inflammation in mice

Multiomics Analysis Reveals Gut Virome-Bacteria-Metabolite Interactions and Their Associations with Symptoms in Patients with IBS-D

Disease-Specific Alterations in the Enteric Virome in Inflammatory Bowel Disease

Human enteric viruses autonomously shape inflammatory bowel disease phenotype through divergent innate immunomodulation

Microbiome and its relevance to indigenous inflammatory bowel diseases in China

The gut virome in inflammatory bowel disease pathogenesis: From metagenomics to novel therapeutic approaches

Community Types of the Human Gut Virome are Associated with Endoscopic Outcome in Ulcerative Colitis

Dynamic impact of virome on colitis and colorectal cancer: Immunity, inflammation, prevention and treatment

Gut microbiota signatures in inflammatory bowel disease

More Positive or More Negative? Metagenomic Analysis Reveals Roles of Virome in Human Disease-Related Gut Microbiome

Characterization of the gut DNA and RNA Viromes in a Cohort of Chinese Residents and Visiting Pakistanis

Gut Virome and Inflammatory Bowel Disease